Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 21;219(1):uxaf023.
doi: 10.1093/cei/uxaf023.

Clinical and experimental treatment of residual immune activation in people living with HIV

Krystelle Nganou-Makamdop  1
Affiliations
Review

Clinical and experimental treatment of residual immune activation in people living with HIV

Krystelle Nganou-Makamdop. Clin Exp Immunol. .

Abstract

Potent inflammatory responses stemming from innate and T cell activation are initiated during acute human immunodeficiency virus infection. Suppression of the virus replication by antiretroviral therapy reduces but does not normalize immune activation. By now, it is clear that residual immune activation can persist even after years of antiretroviral therapy and associates with increased risks for co-morbidities, thereby raising interest for strategies that can resolve the residual immune activation in people with human immunodeficiency virus on antiretrovirals. This brief review reports the human studies with various drugs with anti-inflammatory properties and their effects on measures of systemic immune activation on people with human immunodeficiency virus. Along with the possible reasons for conflicting outcomes, considerations for ongoing and future approaches are outlined.

Keywords: ART; HIV; immune activation; immune reconstitution; inflammation.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Babatunde AO, Akin-Ajani OD, Abdullateef RO, Togunwa TO, Isah HO.. Review of antiretroviral therapy coverage in 10 highest burden HIV countries in Africa: 2015-2020. J Med Virol 2023, 95, e28320. doi: https://doi.org/ 10.1002/jmv.28320 - DOI - PubMed
    1. Kilroy JM, Leal AA, Henderson AJ.. Chronic HIV transcription, translation, and persistent inflammation. Viruses 2024, 16, 751. doi: https://doi.org/ 10.3390/v16050751 - DOI - PMC - PubMed
    1. Colby DJ, Trautmann L, Pinyakorn S, Leyre L, Pagliuzza A, Kroon E.. et al. Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection. Nat Med 2018, 24, 923–6. - PMC - PubMed
    1. Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A.. et al. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: an observational study. PLoS Med 2017, 14, e1002417. doi: https://doi.org/ 10.1371/journal.pmed.1002417 - DOI - PMC - PubMed
    1. Banga R, Perreau M.. The multifaceted nature of HIV tissue reservoirs. Curr Opin HIV AIDS 2024, 19, 116–23. doi: https://doi.org/ 10.1097/COH.0000000000000851 - DOI - PMC - PubMed

MeSH terms